Atrial flutter with 1/1 nodo-ventricular conduction with amiodarone from the physiopathology to diagnosis;Flutter atrial à conduction nodo-ventriculaire 1/1 sous amiodarone: De la physiopathologie au dépistage

Archives des Maladies du Coeur et des Vaisseaux

Volumn 95, Issue 12, 2002, Pages 1181-1187

  Aouate, P ^a   Elbaz, N ^a   Klug, D ^a   Lacotte, J ^a   Raguin, D ^a   Frank, R ^a   Lelouche, D ^a   Dubois Rande J L ^a   Tonet, J ^a   Fontaine, G ^a  

^a HÔPITAL CHARLES FOIX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; CELIPROLOL; DIGOXIN; DILTIAZEM; FLECAINIDE;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FLUTTER; HEART CONDUCTION; HEART PALPITATION; HUMAN; HYPOTENSION; MALE; SYMPTOMATOLOGY; SYNCOPE;

EID: 0036947748     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Aauate P, Frank R, Fontaine G et al. Tachycardie supraventriculaire à QRS larqes survenant sous antiarythmique de la classe I de Waughan-Williarns. Arch Mal Cœur 1995; 88: 1869-74
2. Deharo JC, Durand A, Macaluso G et al. Clinical electrophysiolagic effects of a single high oral dose of amiodarone. Fundam Clin Pharmacal 1997; 11: 275-80.
3. Tieleman RG, Gosselink AT, Crijns HJ et al. Efficacy, safety and determinants of conversion of atrial fibrillatian and flutter with oral amiodarone. Am J Cordial 1997; 79: 53-7.
4. Clemo HF, Wood MA, Gilligan DM, Ellenbogen KA. Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias. Am J Cardial 1998; 81: 594-8
5. Kuruma A, Atarashi H, Ino T, Yashima M, Nomura A, Hayakawa H. Use of intravenous dofetilide in atrial flutter with hemodynamic instability. Jpn Circ J 1996; 60: 67-9.
6. Crijns HJ, Van Gelder IC, Kingma JH, Dunselman PH, Gosselink AT, Lie KI. Atrial flutter can be terminated by class III antiarrhythmic drug but not by a Class IC drug. Eur Heart J 1994; 15: 1403-8.
7. Suarez WA, Van Hare GF, Wexler ID, Arnold JE. Atrial flutter: an uncommon pediatric manifestation of hyperthyroidism. Pediatrics 1997; 100: E11.
8. Garcia GD, Escobar JL, Pinero GC, Giron GJA. Ablation of the hyperconducting atrioventricular node in a patient with thyrotoxicosis induced by amiadarone. Med Clin 1995; 105: 238.
9. Sager PT, Uppal P, Follmer C, Antimisiaris M, Pruitt C, Singh BN. Frequency-dependent electrophysioloqic effects af amiodarone in humans. Circulation 1993; 88: 1063-71.
10. Brugada P, Brugada J, Mont L, Smeets J, Andries E. A new approach to the differential diagnosis of regular tachycardia with a wide QRS camplex. Circulation 1991; 83: 1649-59.
11. Wang Y, Scheinman MM,.Chien WW, Cohen TJ, Lesh MD, Griffin JC. Patients with supraventricular tachycardia presenting with aborted sudden death: incidence, mechanism and long-term follow-up. J Am Coll Cordial 1991; 18: 1711-9.
12. Jackman WM, Prystowsky EN, Naccarelli GV, Fineberg NS, Rahilly GT, Heger JJ. Reevaluation of enhanced atrioventricular nodal conduction: evidence to suggest a continuum of normal atriaventricular nodal physiology. Circulation 1983; 67: 441-8.
13. Brembilla-Perrot B, Houriez P, Beurrier D, Chaudon O, Terrier de la Chaise A, Louis P. Predictors of atrial flutter with 1: 1 conduction in patients treated with class I antiarrhythmic drugs for atrial tachyarrhythmias. Int J Cardiol 2001; 80: 7-15.
14. Vargas G, Akhtar M, Damato AN. Electraphysialogic effects of isoproterenol an cardiac conduction system in man. Am Heart J 1975; 90: 25-34.
15. van den Berg MP, Crijns HJ, Szabo BM, Broouwer J, Lie KI. Effect af exercise on cycle length on atrial flutter. Br Heart J 1995; 73: 263-4.
16. Vitale P, De Stefano R, Auricchio A. Possible danger of rapid intravenous amiodarone in re-entry tachycardia in subjects with Walff-Parkinson-White syndrome. G Ital Cordial 1986; 16: 969-74.
17. Patruno N, Pulignano G, Urbani P, Greco C, Critelli G. Transesophageal pacing in the diagnosis of accelerated atrioventricular conduction. Cardiogia 1989; 34: 87-91.
18. Kennelly BM, Lane GK. Electrophysiological studies in four patients with atrial flutter with 1/1 atriaventricular conduction. Am Heart J 1978; 96: 723-30.
19. Aliot E, Sadoul N, de Chillou C. Rale af the atrioventricular node in atrial fibrillation: what have we learned from radiofrequency catheter modification of the atrioventricular junction in patients with refractory atrial fibrillatian? J Cardiovasc Electrophysiol 1998;. 9: S132-8.
20. Curtis AB, Belardinelli L, Woodard DA, Brown CS, Conti JB. Induction of atrioventricular nade reentrant tachycardia with adenosine: differential effect of adenosine on fast and slow atrioventricular node pathways. J Am Call Cardiol 1997; 30: 1778-84.
21. Belhassen B, Fish R, Eldar M, Glick A, Glikson M, Viskin S. Simplified "ATP test" far noninvasive diagnosis of dual AV nadal physiology and assessment of results af slow pathway ablation in patients with AV nodal reentrant tachycardia. J Cardiovasc Electrophysiol 2000; 11: 255-61.
22. Brodsky MA, Allen BJ, Grimes JA, Gold C. Enhanced atriaventricular conduction durinq atrial flutter after intravenous adenosine. N Engl J Med 1994; 330: 288-9.
23. Vitali A, Della Bello P. Possible pro-arrhythmic effects of vagal stimulation maneuvers. Minerva Cardioangial 1989; 37: 385-8.
24. Denes P, Wu D, Dhingra R, Amat-y-Leon F, Wyndham C, Rosen KM. Dual atrioventricular nodal pathways. A cammon electrophysioloqical response. Br Heart J 1975; 37: 1069-76.
25. Markowitz SM, Stein KM, Mittal S, Lerman BB. Dual atrionadal physiology in the human heart in Mazgalef TN, Tchou PJ. Atrial-AV nadal electrophysiology: a view from the millennium. New York: Futura Publishing Company, 2000: 353-70.
26. Kalbfleisch S J, el-Atassi R, Calkins H, Langberg JJ, Morady F. Association between atrioventricular node reentrant tachycardia and inducible atrial flutter. J Am Call Cardiol 1993; 22: 80-4.
27. Tai CT, Tsai CF, Hseih MH et al. Effects of cavotricuspid isthmus ablation on atrioventricular nade electrophysiology in patients with typical atrial flutter. Circulation 2001; 104: 1501-5.
28. Rokas S, Gaitanidou S, Chatzidou S, Agrios N, Stamatelopoulos S. A noninvasive methad for the detection of dual atrioventricular nade physiology in chronic atrial fibrillation. Am J Cardiol 1999; 84: 1442-5: A8.
29. Tebbenjohanns J, Schumacher B, Korte T, Niehaus M, Pfeiffer D. Bimodal RR interval distribution in chronic atrial fibrillatian: impact of dual atrioventricular nodal physiology on long-term rate control after catheter ablation of the posterior atrianodal input. J Cardiovasc Electrophysial 2000; 11: 497-503.
30. Della Bella P, Carbucicchio C, Tondo C, Riva S. Modulation of atrioventricular conduction by ablation of the "slow" atrioventricular nade pathway in patients with drug refractory atrial fibrillation of flutter. J Am Coll Cardiol 1995; 25: 39-46.